UB Sequential Integration Series I-IV-A

Solanum lycopersicum

Tomato

Tier IUB Sequential Integration Series

Target Trait

1.3×

fold-change

Umami+Bitter-Attenuation sequential pathway fold-change

Technical Specifications

SKU

SS-F-M2-06070

Genomic Edits

GC Content

44.8%

Construct Length

3,121 bp

Promoter System

T7/SP6 cell-free

Expression System

In-vitro cell-free

Host Strain

Cell-free

Receptor Target

mGluR1 + TAS2R38 (suppression)

IFI Score

130

Pathway Edits

mGluR1 pathway primary gene cluster overexpression for umami axis activation
TAS2R38 (suppression) pathway primary gene cluster overexpression for bitter-attenuation axis activation
Bidirectional promoter system for synchronized U+B dual-axis co-expression
Metabolic flux partitioning between IFI-U and IFI-B pathway branches via carbon flow optimization
Transcription factor co-binding site engineering for Umami-Bitter-Attenuation combinatorial gene regulation

Key Interventions

Dual-receptor co-activation via synchronized mGluR1 and TAS2R38 (suppression) pathway engineeringMetabolic flux partitioning strategy enabling simultaneous umami and bitter-attenuation accumulation without competing pathway suppressionSequential construct stacking for UB multi-axis integrationCell-free co-translation of multi-axis enzyme sets for in-vitro biochemical validation

IFI Subscale Profile

IFI Profile

IFI-S

—

IFI-U

—

IFI-B

—

IFI-K

—

IFI-C

—

IFI-P

—

IFI-A

—

IFI-F

—

Use Case

Tier I UB dual-axis sequential integration platform for food ingredient applications requiring verified combined umami+bitter-attenuation sensory character. Suitable for multi-modal flavor architecture, premium ingredient certification, and receptor-confirmed IFI multi-axis profiling.

License

$299 · Tier I License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-M All Modalities